首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Molecular Evaluation of DNMT3A and IDH1/2 Gene Mutation: Frequency, Distribution Pattern and Associations with Additional Molecular Markers in Normal Karyotype Indian Acute Myeloid Leukemia Patients
【24h】

Molecular Evaluation of DNMT3A and IDH1/2 Gene Mutation: Frequency, Distribution Pattern and Associations with Additional Molecular Markers in Normal Karyotype Indian Acute Myeloid Leukemia Patients

机译:DNMT3A和IDH1 / 2基因突变的分子评价:频率,分布模式和额外分子标志物在正常核型印度急性髓性白血病患者中的额外分子标志物

获取原文
获取外文期刊封面目录资料

摘要

Mutations in the DNMT3A and IDH genes represent the most common genetic alteration after FLT3/NPM1 in acute myeloid leukemia (AML). We here analyzed the frequency and distribution pattern of DNMT3A and IDH mutations and their associations with other molecular markers in normal karyotype AML patients. Fortyfive patients were screened for mutations in DNMT3A (R882), IDH1 (R132) and IDH2 (R140 and R172) genes by direct sequencing. Of the 45 patients screened, DNMT3A and IDH mutations were observed in 6 (13.3%) and 7 (15.4%), respectively. Patients with isolated DNMT3A mutations were seen in 4 cases (9%), isolated IDH mutations in 5 (11.1%), while interestingly, two cases showed both DNMT3A and IDH mutations (4.3%). Nucleotide sequencing of DNMT3A revealed missense mutations (R882H and R882C), while that of IDH revealed R172K, R140Q, R132H and R132S. Both DNMT3A and IDH mutations were observed only in adults, with a higher frequency in males. DNMT3A and IDH mutations were significantly associated with NPM1, while trends towards higher coexistence with FLT3 mutations were observed. This is the first study to evaluate DNMT3A/IDH mutations in Indian patients. Significant associations among the various molecular markers was observed, that highlights cooperation between them and possible roles in improved risk stratification.
机译:DNMT3A和IDH基因中的突变代表了FLT3 / NPM1在急性髓性白血病(AML)中最常见的遗传改变。我们在这里分析了DNMT3A和IDH突变的频率和分布模式及其与正常核型AML患者中其他分子标记的关联。通过直接测序筛选DNMT3A(R882),IDH1(R132)和IDH2(R140和R172)基因中的突变筛选的Fortyfive患者。在筛选的45名患者中,在6(13.3%)和7(15.4%)中分别观察到DNMT3A和IDH突变。在4例(9%)中观察到患有分离的DNMT3A突变,分离的IDH突变5(11.1%),同时有趣的是,两种情况显示DNMT3A和IDH突变(4.3%)。 DNMT3A的核苷酸测序揭示了麦基义突变(R882H和R882C),而IDH的核苷酸突变揭示了R172K,R140Q,R132H和R132s。仅在成人中观察到DNMT3A和IDH突变,均为较高的母体频率。 DNMT3A和IDH突变与NPM1显着相关,而观察到与FLT3突变更高共存的趋势。这是第一次评估印度患者DNMT3A / IDH突变的研究。观察到各种分子标志物之间的显着关联,突出了它们之间的合作和可能的角色在提高风险分层之间。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号